Isolated Presence of Antibody to Hepatitis B Core Antigen in Injection Drug Users: Do They Need to Be Vaccinated?
Open Access
- 15 May 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (10) , e143-e144
- https://doi.org/10.1086/320162
Abstract
In a study of 497 injection drug users who had isolated presence of antibody to hepatitis B core antigen (anti-HBc) at the time of enrollment, 404 (8Keywords
This publication has 5 references indexed in Scilit:
- The Significance of Isolated Antibody to Hepatitis B Core Antigen Seropositivity in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Clinical Aspects of the Interactions Between Human Immunodeficiency Virus and the Hepatotropic VirusesClinical Infectious Diseases, 1994
- Prevalence of Anti-HBc in Anti-HBs Positive Individuals: Implications for Selecting Vaccine CandidatesAmerican Journal of Clinical Pathology, 1984
- Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigensJournal of Clinical Microbiology, 1984